2024 Annual Report Vistin Pharma ASA

Seeking Alpha / 49 minutes from now 1 Views

Oslo, Norway, 25 April 2025

Meridian Corporation Reports First Quarter 2025 Results and Announces a Quarterly Dividend of $0.125 per Common Share

3 hours from now
HPQ Silicium : Correction de communiqués antérieurs

3 hours from now
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC

3 hours from now
ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

3 hours from now
Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025

3 hours from now